Methods for biomolecule and biomolecule complex (BMC) detection and analysis and the use of such for research and medical diagnosis
AssigneeUniversity of Central Florida Research Foundation, Inc.
InventorQun Huo
Life of this patent
Estimating the term…
Abstract
The present application pertains to improved methods of detecting biomolecules in a biological sample (or system), In particular, embodiments discussed herein allow for the detection of biomolecule complexes. The embodiments enable for the first time the elucidation of the significance of biomolecule complexes for certain disease states, which in turn enables the diagnosis of disease states based on the identity and complexing level of a biomolecule complex in a particular biological sample.
Claims16
A method for detecting a biomolecule complex in a biological sample, said method comprising
- producing a first assay product by contacting a biological sample with a first nanoparticle probe, said first nanoparticle probe comprising a nanoparticle bound to a first baiting molecule specific to a first target molecule of interest;
- contacting the first assay product with a second baiting molecule specific to a second target molecule of interest to produce a second assay product;
- and
- detecting by particle analysis for presence of nanoparticle probe bound to said first target molecule of interest, or for presence of said second target molecule of interest in said second assay product, or both, wherein if both, a complex of the first and second target molecules is present in the biological sample.
A method for detecting a target molecule in a biological sample, said method comprising
- (a) obtaining a first assay product that has been produced by contacting a biological sample with a first nanoparticle probe, said first nanoparticle probe comprising a nanoparticle bound to a first baiting molecule specific to a first target molecule of interest;
- (b) subjecting said first assay product to a second nanoparticle probe comprising a second baiting molecule that is specific to a second target molecule of interest to produce a second assay product;
- and
- (c) detecting for presence of second nanoparticle probe bound to said second target molecule of interest in said second assay product, wherein if the second nanoparticle probe bound to said second target molecule of interest is detected, the second target molecule of interest is present in the biological sample;
- and further comprising detecting presence of first nanoparticle probe bound to said first target molecule of interest in said first assay product before step (c), wherein a biomolecule complex of said first and second target molecules of interest is detected based on a difference in size between said first assay product and said second assay product.
A method for detecting at least one biomolecule in a biological sample, said method comprising obtaining a first assay product produced by contacting a biological sample with a nanoparticle, wherein said contacting forms a biomolecule corona on the nanoparticle surface, and conducting particle analysis of the first assay product;
- and further comprising (i) using biomolecule corona size information for detection, diagnosis and/or prognosis of a disease by comparing the biomolecule corona size information with size information from a known sample, or (ii) contacting said first assay product with a baiting molecule that binds specifically to a target molecule of interest to form a second assay product, and detecting the presence and/or quantity of the target molecule of interest by particle analysis.
Dependencies are inferred from the claim text.